资讯

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...
A recent clinical trial reveals that Wegovy, a popular weight-loss drug containing semaglutide, shows promising results in ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...
In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...
A recent clinical trial reveals that Wegovy, a popular weight-loss drug containing semaglutide, shows promising results in treating liver diseases like MASH. The study, published in the New ...